{
    "LeadSponsorName": [
        "AstraZeneca",
        "GlaxoSmithKline",
        "mAbxience Research S.L.",
        "Heidelberg Pharma AG",
        "PTC Therapeutics",
        "Eidos Therapeutics, a BridgeBio company",
        "Wyeth is now a wholly owned subsidiary of Pfizer",
        "Regeneron Pharmaceuticals",
        "BeiGene",
        "BioMarin Pharmaceutical",
        "Bristol-Myers Squibb",
        "Ultragenyx Pharmaceutical Inc",
        "Tobira Therapeutics, Inc.",
        "EMD Serono Research & Development Institute, Inc.",
        "UCB BIOSCIENCES GmbH",
        "Janssen Pharmaceutica",
        "Alexion",
        "R-Pharm",
        "Sandoz",
        "Astellas Pharma Global Development, Inc.",
        "Incyte Corporation",
        "Eurofarma Laboratorios S.A.",
        "Merrimack Pharmaceuticals",
        "Genmab",
        "Ligand Pharmaceuticals",
        "F2G Biotech GmbH",
        "Synta Pharmaceuticals Corp.",
        "Recombio SL",
        "Biocinese",
        "PharmaMar",
        "Crinetics Pharmaceuticals Inc.",
        "Lavilabor Natural Products Ltd",
        "Shire",
        "CancerVax Corporation",
        "Advaxis, Inc.",
        "Genentech, Inc.",
        "ISA Pharmaceuticals",
        "Baxalta now part of Shire",
        "Bayer",
        "Cogent Biosciences, Inc.",
        "AbbVie (prior sponsor, Abbott)",
        "CSL Behring",
        "Janssen-Cilag Ltd.",
        "Janssen-Cilag Farmaceutica Ltda.",
        "AVEO Pharmaceuticals, Inc.",
        "Otsuka Pharmaceutical Development & Commercialization, Inc.",
        "Apellis Pharmaceuticals, Inc.",
        "Libbs Farmac\u00eautica LTDA",
        "Chiltern Pesquisa Clinica Ltda",
        "OncoVerity, Inc.",
        "Taiho Oncology, Inc.",
        "Atos Medical AB",
        "Polyphor Ltd.",
        "Tesaro, Inc.",
        "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
        "Xcovery Holding Company, LLC",
        "Gamida Cell ltd",
        "Halozyme Therapeutics",
        "Asahi Kasei Pharma America Corporation",
        "Mylan Inc.",
        "Telik",
        "medac GmbH",
        "ColubrisMX",
        "Loxo Oncology, Inc.",
        "Mallinckrodt",
        "Boston Scientific Corporation",
        "Janssen Sciences Ireland UC",
        "RECORDATI GROUP",
        "OBI Pharma, Inc",
        "ViiV Healthcare",
        "Cryopraxis Criobiologia Ltda.",
        "Kyowa Kirin, Inc.",
        "pharmaand GmbH",
        "Sumitomo Pharma America, Inc.",
        "CanariaBio Inc.",
        "Clovis Oncology, Inc.",
        "AbbVie",
        "Sophia Genetics SAS",
        "Myovant Sciences GmbH",
        "Vical",
        "Principia Biopharma, a Sanofi Company",
        "Janssen Research & Development, LLC",
        "Genzyme, a Sanofi Company",
        "EOM Pharmaceuticals",
        "Abivax S.A.",
        "Immix Biopharma, Inc.",
        "Active Biotech AB",
        "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
        "Celcuity, Inc.",
        "Janssen Vaccines & Prevention B.V.",
        "Ipsen",
        "Kronos Bio",
        "Corcept Therapeutics",
        "Daiichi Sankyo, Inc.",
        "Janssen Pharmaceutica N.V., Belgium",
        "Eisai Inc.",
        "Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional S/A",
        "Inovio Pharmaceuticals",
        "bluebird bio",
        "Amgen",
        "Puma Biotechnology, Inc.",
        "Azidus Brasil",
        "Boehringer Ingelheim",
        "Celldex Therapeutics",
        "Becton, Dickinson and Company",
        "SciClone Pharmaceuticals",
        "Novartis",
        "HUYABIO International, LLC.",
        "Nektar Therapeutics",
        "Zodiac Produtos Farmaceuticos S.A.",
        "Isarna Therapeutics GmbH",
        "Intercept Pharmaceuticals",
        "Millennium Pharmaceuticals, Inc.",
        "Human Genome Sciences Inc., a GSK Company",
        "Recepta Biopharma",
        "NovoCure Ltd.",
        "Celgene",
        "Geron Corporation",
        "Merck KGaA, Darmstadt, Germany",
        "Telios Pharma, Inc.",
        "Novartis Pharmaceuticals",
        "Immune Biosolutions Inc",
        "Agenus Inc.",
        "Janssen Scientific Affairs, LLC",
        "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
        "Checkpoint Therapeutics, Inc.",
        "EMD Serono",
        "ApoPharma",
        "Guerbet",
        "RayzeBio, Inc.",
        "Cellectar Biosciences, Inc.",
        "Morphotek",
        "Takeda",
        "Basilea Pharmaceutica",
        "Gilead Sciences",
        "Bioverativ Therapeutics Inc.",
        "Merck Sharp & Dohme LLC",
        "Alaunos Therapeutics",
        "UCB Pharma",
        "Hoffmann-La Roche",
        "OSI Pharmaceuticals",
        "Akeso",
        "Astellas Pharma Inc",
        "Scitech Produtos Medicos Ltda",
        "Acerta Pharma BV",
        "Mirati Therapeutics Inc.",
        "Viracta Therapeutics, Inc.",
        "Sanofi",
        "Abbott",
        "R-Pharm International, LLC",
        "Sesen Bio, Inc.",
        "Tolmar Inc.",
        "Algenis SpA",
        "NantCell, Inc.",
        "Pfizer",
        "Agios Pharmaceuticals, Inc.",
        "Brooklyn ImmunoTherapeutics, LLC",
        "Spectrum Pharmaceuticals, Inc",
        "Tularik",
        "Seagen Inc.",
        "Aragon Pharmaceuticals, Inc.",
        "Arcus Biosciences, Inc.",
        "Shionogi",
        "Teva Branded Pharmaceutical Products R&D, Inc.",
        "Applied Biology, Inc.",
        "Jazz Pharmaceuticals",
        "Humanigen, Inc.",
        "Threshold Pharmaceuticals",
        "Kartos Therapeutics, Inc.",
        "Anthera Pharmaceuticals",
        "Novo Nordisk A/S",
        "Biozeus Biopharmaceutical S.A.",
        "Pierre Fabre Medicament",
        "BioNTech SE",
        "Biogen",
        "Debiopharm International SA",
        "Eli Lilly and Company",
        "Nereus Pharmaceuticals, Inc.",
        "Exelixis",
        "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
        "Helsinn Healthcare SA"
    ]
}